Drug Shortages

Commitment to supply resiliency

As part of the ongoing strategy to end supply interruptions, the Vizient team of pharmacy experts has identified 200 essential medications in a recent report. Any shortages of these medications would prove a critical threat to providing immediate and high-quality patient care.

Download the report to view these essential medications, which are grouped in the three categories below. Many of these medications are available through the Vizient Novaplus private label program.

  • Acute treatment drugs with no alternatives (56 medications)
  • Chronic treatment drugs with no alternatives (21 medications)
  • High impact drugs (123 medications)

Download Essential Medications report

Complete the form below to download the report

The hidden costs of drug shortages

Between March 6 and April 4, 2019, the Vizient Drug Shortages Task Force conducted its inaugural member survey to uncover the unseen impacts of drug shortages.

The responses — collected from member organizations across the continuum of care — confirmed that drug shortages are a global issue, affecting all types of care facilities and taking a significant toll on pharmacy resources, budgets, staffing and patient care delivery.

Download the full report to learn key strategies hospitals are using to manage drug shortages, find out
what hospital roles are impacted the most and to gain insights into Vizient solutions that help mitigate and
end drug shortages. 

200 medications

essential to patient care

$359M per year

Cost of labor needed to manage drug shortages per year

8.6M hours annually

Additional hours of labor per year

Read key insights by role


Access takeaways tailored to health system leaders, including C-suite.

Pharmacy directors

Discover customized takeaways for pharmacy directors from the survey results.

Buyers and technicians

Find survey takeaways relevant to those in pharmacy buyer or technician roles.

Connect with Vizient to find out how we can help you manage drug shortages or to learn about our other pharmacy initiatives.